X

Vous n'êtes pas connecté

Rubriques :

  - WN.COM - Health - 22/Jul 10:35

Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline

Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline Paris, July 22, 2025. Sanofi today announces it has entered into an agreement to acquire Vicebio Ltd (“Vicebio”), a privately held biotechnology company headquartered in London, UK. The acquisition brings an early-stage combination vaccine candidate for respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), both respiratory viruses, and expands the capabilities in vaccine design and development with Vicebio’s ‘Molecular Clamp’ technology. The vaccine candidate complements Sanofi’s position in the respiratory vaccines space where the company is present in flu and RSV prevention. It allows Sanofi to...

Articles similaires

Sorry! Image not available at this time

Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline

wn.com - 22/Jul 10:35

Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline Paris, July 22, 2025. Sanofi today announces it has entered into an agreement to...

Sorry! Image not available at this time

Billion-dollar deal takes UQ vaccine tech to the world

aumanufacturing.com.au - 23/Jul 01:43

The University of Queensland’s Molecular Clamp technology has been acquired by global healthcare giant Sanofi in a landmark deal worth up to US$1.6...

Sorry! Image not available at this time

Seniors With RSV-Linked Hospitalization Have Increased Cardiovascular Outcomes

drugs.com - 24/Jul 20:33

THURSDAY, July 24, 2025 -- In older adults, respiratory syncytial virus (RSV) is associated with an increased risk for cardiovascular outcome,...

Sorry! Image not available at this time

New mRNA Vaccine Shows Promise in Boosting Cancer Immunity

greekreporter.com - 30/Jul 21:58

A new experimental mRNA vaccine could boost the immune system’s ability to fight cancer and improve the effectiveness of existing treatments,...

Sorry! Image not available at this time

New mRNA Vaccine Shows Promise in Boosting Cancer Immunity

greekreporter.com - 30/Jul 21:58

A new experimental mRNA vaccine could boost the immune system’s ability to fight cancer and improve the effectiveness of existing treatments,...

Sorry! Image not available at this time

Nirsevimab Effective for Protecting Infants From RSV Lower Respiratory Tract Disease

drugs.com - 30/Jul 15:07

WEDNESDAY, July 30, 2025 -- Nirsevimab is effective for protecting infants against respiratory syncytial virus (RSV)-associated lower respiratory...

Sorry! Image not available at this time

Nirsevimab Effective for Protecting Infants From RSV Lower Respiratory Tract Disease

drugs.com - 30/Jul 15:07

WEDNESDAY, July 30, 2025 -- Nirsevimab is effective for protecting infants against respiratory syncytial virus (RSV)-associated lower respiratory...

Sorry! Image not available at this time

SPOTLIGHT OP-ED: New respiratory virus vaccine a game changer for babies, but cost remains a barrier

daily maverick - 22/Jul 19:05

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa’s private sector, but not yet in...

Sorry! Image not available at this time

SPOTLIGHT OP-ED: New respiratory virus vaccine a game changer for babies, but cost remains a barrier

daily maverick - 22/Jul 19:05

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa’s private sector, but not yet in...

Sorry! Image not available at this time

35 Percent of Eligible Children Receive RSV Prophylaxis With Nirsevimab

drugs.com - 22/Jul 15:07

TUESDAY, July 22, 2025 -- Despite near universal availability of nirsevimab, only 35 percent of eligible children receive nirsevimab for respiratory...

Les derniers communiqués